Trial · NCT02806791
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Collection of autologous stem cells (time the median of achieving> 20 CD34 + / ul circulating) | until reaching 20,000 platelets (2006-2015) | |
| Primary | Trend in blood counts after discharge values | Until day +75 post autologous transplantation (2006-2015) | |
| Primary | Collection of autologous stem cells (total hematopoietic stem cells CD34 + * 10 ^ 6 / kg collected) | at the moment of the collection of autologous stem cells (2006-2015) | |
| Primary | Collection of autologous stem cells (the median time from the first day of chemotherapy mobilizing) | from the first day of chemotherapy mobilizing (2006-2015) | the median time (in days) from the first day of chemotherapy mobilizing the effective collection of stem cells |
| Primary | Collection of autologous stem cells (the median number of leukapheresis performed) | at the moment of the collection of autologous stem cells (2006-2015) | |
| Primary | Collection of autologous stem cells (median number of white blood cells) | at the moment of the collection of autologous stem cells | the median number of white blood cells in the process of mobilization |
| Primary | Collection of autologous stem cells ( with the aid of Plerixafor) | at the moment of the collection of autologous stem cells (2006-2015) | the proportion of patients who have the mobilized peripheral blood stem cells with the aid of Plerixafor |
| Primary | Engraftment after autologous transplantation (granulocyte and platelet engraftment) | from transplant to engraftment (2006-2015) | cumulative incidence of granulocyte and platelet engraftment |
| Primary | Engraftment after autologous transplantation ( median time to achieve neutrophils> 500) | from transplant to platelets engraftment (2006-2015) | the median time to achieve neutrophils\> 500 / ul for 3 consecutive days / platelets\> 20,000 / ul for 7 consecutive days |
| Primary | Engraftment after autologous transplantation (the median number of days of G-CSF administration) | from transplant to engraftment (2006-2015) | |
| Primary | Engraftment after autologous transplantation (median number of days of aplasia) | from transplant to engraftment (2006-2015) | |
| Primary | Engraftment after autologous transplantation (median length of stay) | from transplant to engraftment (2006-2015) | |
| Primary | Engraftment after autologous transplantation (number of transfusions) | from transplant to platelets engraftment (2006-2015) | number of transfusions of packed red cells and platelet pool / patient needed |
| Secondary | transplant-related mortality | from transplant to death (if applicable) (2006-2015) | |
| Secondary | Overall survival (overall survival, OS) | to a year from autologous (2006-2015) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02806791/registered